Novozymes A/S B buy RudolfL
Start price
26.01.20
/
50%
€46.87
Target price
13.08.20
€53.00
Performance (%)
5.33%
End price
13.08.20
€49.37
Summary
This prediction ended on 13.08.20 with a price of €49.37. With a performance of 5.33%, the BUY prediction by RudolfL for Novozymes A/S B closed with a slight gain. Dividends of €0.70 are taken into consideration when calculating the performance. RudolfL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Novozymes A/S B | -2.758% | -2.758% | 54.210% | -6.577% |
iShares Core DAX® | 1.510% | 2.268% | 18.541% | 18.577% |
iShares Nasdaq 100 | -0.271% | -1.533% | 22.755% | 34.901% |
iShares Nikkei 225® | -0.108% | 0.411% | 10.352% | -0.876% |
iShares S&P 500 | 0.479% | 0.563% | 22.881% | 38.847% |
According to RudolfL what are the pros and cons of Novozymes A/S B for the foreseeable future?
Pros
Market Leader or Top 3
Higher EBIT margin than peer group
positive Cash Flow expected
ROE higher than 15% per year
Cons
Revenue decline/stagnation expected
Comments by RudolfL for this prediction
In the thread Novozymes A/s Nam. B diskutieren
Buy mit Kursziel 53,0
In the thread Trading Novozymes A/s Nam. B
Buy beendet
Stopped prediction by RudolfL for Novozymes A/S B
Novozymes A/S B
Start price
Target price
Perf. (%)
€55.52
11.09.20
11.09.20
€63.00
04.11.21
04.11.21
18.70%
05.11.21
05.11.21
Market Leader or Top 3
Higher EBIT margin than peer group
positive Cash Flow expected
Revenue decline/stagnation expected